April 2024 in “Vestnik oftalʹmologii” In this case report, a 31-year-old male using topical minoxidil for androgenic alopecia developed diplopia and increased intraocular pressure, which improved after stopping minoxidil and using prostaglandin analogues, although a carbonic anhydrase inhibitor caused IOP to rise again during follow-up.
23 citations
,
April 2010 in “Clinical, cosmetic and investigational dermatology” This review discusses the cutaneous application of bimatoprost ophthalmic solution 0.03% for enhancing upper eyelash growth and suggests it is both safe and effective; no new clinical results are reported.
12 citations
,
December 2018 in “Clinical Ophthalmology” This review summarizes clinical trials and comparative studies showing that latanoprostene bunod 0.024% is effective and safe for reducing intraocular pressure in patients with open-angle glaucoma or ocular hypertension, detailing its mechanism and side effects while considering its therapeutic role.
6 citations
,
April 2015 in “Plastic surgical nursing” This study reports that applying bimatoprost ophthalmic solution 0.03% to the upper eyelid margin enhances eyelash growth by increasing length, thickness, and darkness, with a favorable safety profile.
30 citations
,
August 2009 in “Journal of the American Academy of Dermatology” This study found that while bimatoprost was safe for 16 weeks, it was not effective for eyelash growth in patients with significant loss due to alopecia areata, though some with less loss experienced growth.